Product/Composition:- | Metoprolol |
---|---|
Strength:- | IR: 25 mg, 50 mg, 100 mg; ER: 25 mg, 50 mg, 100 mg, 200 mg |
Form:- | Tablets(IR & ER) |
Reference Brands:- | US: Lopressor(IR); Toprol-XL(ER) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Metoprolol is a selective beta-1 blocker that reduces heart rate, blood pressure, and cardiac output by inhibiting adrenaline effects on the heart. It effectively manages hypertension, angina, and heart failure. Benefits include decreased cardiovascular workload, reduced risk of heart attack, improved heart rhythm, and overall cardiovascular health.
Metoprolol tablets, marketed as Lopressor and Toprol-XL, are approved in the US by the FDA and in the EU via EMA for hypertension, angina, and heart failure management. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial data and manufacturing quality for timely approval, while the EMA ensures compliance with regional safety and quality standards. For dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Proper adherence supports rapid approval, safe use, and worldwide availability, helping improve cardiovascular health outcomes globally.